Comparative pharmacokinetics of dirithromycin and erythromycin in normal volunteers with special regard to accumulation in polymorphonuclear leukocytes and in saliva

European Journal of Clinical Pharmacology

Volumn 53, Issue 2, 1997, Pages 127-133

  Geerdes Fenge, H F ^a   Goetschi, B ^a   Rau, M ^a   Borner, K ^a   Koeppe, P ^a   Wettich, K ^b   Lode, H ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b LILLY DEUTSCHLAND GMBH   (Germany)

Author keywords

Accumulation; Dirithromycin; Erythromycin; Polymorphonuclear leukocytes; Saliva

Indexed keywords

DIRITHROMYCIN; DRUG METABOLITE; ERYTHROMYCIN; ERYTHROMYCYLAMINE;

ADULT; ARTICLE; BIOASSAY; BIOAVAILABILITY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG SALIVA LEVEL; DRUG URINE LEVEL; FEMALE; FILM COATING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; MEAN RESIDENCE TIME; MICROCOCCUS LUTEUS; NEUTROPHIL; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SALIVA; TABLET;

ADMINISTRATION, ORAL; ADULT; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; ERYTHROMYCIN; FEMALE; HALF-LIFE; HUMANS; MACROLIDES; MALE; NEUTROPHILS; SALIVA;

EID: 0030784932     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050350     Document Type: Article

References (36)

1. Abdelghaffar H, Mtairag EM, Labro MT (1994) Effects of dirithromycin and erythromycylamine on human neutrophil degranulation. Antimicrob Agents Chemother 38: 1548-1554
2. Barza M (1994) Tissue-directed antibiotic therapy: antibiotic dynamics in cells and tissue. Challenges to antibiotic activity in tissue. Clin Infect Dis 19: 910-915
3. Baughman RP, DeSante KA, Lanier TL, Conforti PM, Sides GD (1994) The penetration of dirithromycin into bronchoalveolar lavage fluid and alveolar macrophages. J Antimicrob Chemother 33: 1045-1050
4. Bergogne-Bérézin E (1993) Tissue distribution of macrolide antibiotics. In: Bryskier AJ, Butzler JP, Neu HD, Tulkens PM (eds) Macrolides chemistry, pharmacology and clinical use. Arnette Blackwell, Paris, pp 451-484
5. Bertazzoni Minelli E, Console U, Migliolo PA, Bert T (1991) Different mechanisms of salivary excretion of macrolides. J Chemother [Suppl. 4]: 238-239
6. Borner K, Borner E, Lode H, Rau M, Goetschi B (1994) Determination of erythromycylamine, a recent macrolide antibiotic. Klin Lab 40: 815-820
7. Brogden RN, Peters DH (1994) Dirithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 48: 599-616
8. Bryskier A, Labro MT (1994) Macrolides-nouvelles perspectives thérapeutiques. Presse Med 23: 1762-1766
9. Butts JD (1994) Intracellular concentrations of antibacterial agents and related clinical implications. Clin Pharmacokinet 27: 63-84
10. Counter FT, Ensminger PW, Preston DA, Wu CE, Greene JM, Felty-Duckworth AM, Paschal JW, Kirst HA (1991) Synthesis and antimicrobial evaluation of dirithromycin, a new macrolide antibiotic derived from erythromycin. Antimicrob Agents Chemother 35: 1116-1126
11. Croteau D, Vallée F, Bergeron MG, Lebel M (1987) High-performance liquid chromatography assay of erythromycin and its esters using electrochemical detection. J Chromatogr 419: 202-212
12. Duthu GS (1984) Assay of erythromycin from human serum by high-performance liquid chromatography with electrochemical detection. J Liquid Chromatogr 7: 1023-1032
13. Foulds G, Shepard RM, Johnson RB (1990) The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 25[Suppl A]: 73-82
14. Gladue RP, Bright GM, Isaacson RE, Newborg MF (1989) In vitro and in vivo uptake of azithromycin (CP-62, 993) by phagocytic cells: possible mechanism of delivery and release at site of infection. Antimicrob Agents Chemother 33: 277-282
15. Hand WL, Hand DL (1993) Interactions of dirithromycin with human polymorphonuclear leukocytes. Antimicrob Agents Chemother 37: 2557-2562
16. Henry J, Garland M, Turner P, Esmieu F (1980) Plasma and salivary concentrations of erythromycin after administration of three different formulations. Postgrad Med J 55: 707-710
17. Ishiguro M, Koga H, Kohomo S, Hayashi T, Yamaguchi K, Hirota M (1989) Penetration of macrolides into human polymorphonuclear leucocytes. J Antimicrob Chemother 24: 719-729
18. Kirst HA, Sides GD (1989) New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy. Antimicrob Agents Chemother 33: 1419-1422
19. Kirst HA, Sides GD (1993) Bioavailability of macrolide antibiotics. In: Bryskier AJ, Butzler JP, Neu HD, Tulkens PM (eds) Macrolides - chemistry, pharmacology and clinical use. Arnette Blackwell, Paris, pp 441-449
20. Labro MT (1993) Intraphagocytic penetration of macrolide antibiotics. In: Bryskier AJ, Butzler JP, Neu HD, Tulkens PM (eds) Macrolides - chemistry, pharmacology and clinical use. Arnette Blackwell, Paris, pp 379-388
21. Lindstrom TD, Hanssen BR, Wrighton SA (1993) Cytochrom P-450 complex formation by dirithromycin and other macrolides in rat and human livers. Antimicrob Agents Chemother 37: 265-269
22. Lode H, Stahlmann R, Koeppe P (1979) Comparative pharmacokinetics of cephalexin, cefaclor, cefadroxil, and CGP-9000. Antimicrob Agents Chemother 16: 1-6
23. Lode H, Garau J, Grassi C, Hosie J, Huchon G, Legakis N, Segev S, Wijmands G (1995) Treatment of community-acquired pneumonia: a randomized comparison of sparfloxacin, amoxycillin-clavulanic acid and erytrhomycin. Eur Respir J 8: 1999-2007
24. Mtairag EM, Abdelghaffar H, Labro MT (1994) Investigation of dirithromycin and erythromycylamine uptake by human neutrophils in vitro. J Antimicrob Chemother 33: 523-536
25. Mtairag EM, Abdelghaffar H, Douhet C, Labro MT (1995) Role of extracellular calcium in in vitro uptake and intraphagocytic location of macrolides. Antimicrob Agents Chemother 39: 1676-1682
26. Nilsen OG (1995) Pharmacokinetics of macrolides. Comparison of plasma, tissue and free concentrations with special reference to roxithromycin. Infection 23 [Suppl 1]: S5-S9
27. Nix DE, Goodwin SD, Peloquin CA, Rotella DL, Schentag JJ (1991) Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response. Antimicrob Agents Chemother 35: 1953-1959
28. Reeves DS, Bywater MJ (1976) Assay of antimicrobial agents. In: J. de Louvois (ed) Selected topics of clinical bacteriology. Bailliere Tindall, London, pp 21-78
29. Schentag JJ (1991) Tissue-directed pharmacokinetics. Am J Med 91[Suppl 3A]: 5S-11S
30. Schlick W (1993) The problems of treating atypical pneumonia. J Antimicrob Chemother 31 [Suppl C]: 111-120
31. Schwarz G (1978) Estimating the dimension of a model. Ann Statistics 6: 461-464
32. Sides GD, Cerimele BJ, Black HR, Busch U, DeSante KA (1993) Pharmacokinetics of dirithromycin. J Antimicrob Chemother 31 [Suppl C]: 65-75
33. Steinhoff D, Lode H, Ruckdeschel G, Heidrich B, Rolfs A, Fehrenbach FJ, Mauch H, Höffken G, Wagner J (1996) Contribution of Chlamydia pneumoniae to the etiology of community-acquired-pneumonia in hospitalized patients in Berlin, Germany. Clin Infect Dis 223: 958-964
34. Stephen KW, McCrossan J, Mackenzie D (1980) Factors determing the passage of drugs from blood into saliva. Br J Clin Pharmacol 9: 51-55
35. Vogel F (1995) A guide to the treatment of lower respiratory tract infections. Drugs 50: 62-72
36. Williams JD, Sefton AM (1993) Comparison of macrolide antibiotics. J Antimicrob Chemother 31 [Suppl C]: 11-26